These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 25577176
1. Intravenous immunoglobulin for chronic residual peripheral neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a multicenter, double-blind trial. Koike H, Akiyama K, Saito T, Sobue G, Research Group for IVIg for EGPA/CSS in Japan. J Neurol; 2015 Mar; 262(3):752-9. PubMed ID: 25577176 [Abstract] [Full Text] [Related]
5. Heart failure not responsive to standard immunosuppressive therapy is successfully treated with high dose intravenous immunoglobulin therapy in a patient with Eosinophilic Granulomatosis with Polyangiitis (EGPA). Pecoraro A, Crescenzi L, Carucci L, Genovese A, Spadaro G. Int Immunopharmacol; 2017 Apr; 45():13-15. PubMed ID: 28152445 [Abstract] [Full Text] [Related]
7. Intravenous immunoglobulin for chronic residual peripheral neuropathy in microscopic polyangiitis: A multicentre randomised double-blind trial. Arimura Y, Sobue G, Hattori N, Takashima H, Harigai M, Nagata K, Makino H. Mod Rheumatol; 2023 Nov 01; 33(6):1125-1136. PubMed ID: 36346309 [Abstract] [Full Text] [Related]
8. Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin. Tsurikisawa N, Taniguchi M, Saito H, Himeno H, Ishibashi A, Suzuki S, Akiyama K. Ann Allergy Asthma Immunol; 2004 Jan 01; 92(1):80-7. PubMed ID: 14756469 [Abstract] [Full Text] [Related]
9. Efficacy of Early Intravenous Immunoglobulin for Eosinophilic Granulomatosis With Polyangiitis Associated With Acute Bilateral Symmetrical Peripheral Neuropathy and Posterior Cranial Nerve Involvement: A Case Report. Chen Y, Liao SJ, Zhang WX, Feng HY. J Clin Rheumatol; 2021 Dec 01; 27(8S):S672-S673. PubMed ID: 33264244 [No Abstract] [Full Text] [Related]
12. Efficacy of early intravenous immunoglobulin for eosinophilic granulomatosis with polyangiitis with drastically progressive neuropathy: a synopsis of two cases. Matsumoto T, Otsuka K, Kawamoto M, Nagata K, Tachikawa R, Imai Y, Oka N, Tomii K. Intern Med; 2013 Dec 01; 52(8):913-7. PubMed ID: 23583996 [Abstract] [Full Text] [Related]
13. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study. Moon DE, Lee DI, Lee SC, Song SO, Yoon DM, Yoon MH, Kim HK, Lee YW, Kim C, Lee PB. Clin Ther; 2010 Dec 01; 32(14):2370-85. PubMed ID: 21353106 [Abstract] [Full Text] [Related]
15. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis. Wechsler ME, Akuthota P, Jayne D, Khoury P, Klion A, Langford CA, Merkel PA, Moosig F, Specks U, Cid MC, Luqmani R, Brown J, Mallett S, Philipson R, Yancey SW, Steinfeld J, Weller PF, Gleich GJ, EGPA Mepolizumab Study Team. N Engl J Med; 2017 May 18; 376(20):1921-1932. PubMed ID: 28514601 [Abstract] [Full Text] [Related]
16. Response of vasculitic peripheral neuropathy to intravenous immunoglobulin. Levy Y, Uziel Y, Zandman G, Rotman P, Amital H, Sherer Y, Langevitz P, Goldman B, Shoenfeld Y. Ann N Y Acad Sci; 2005 Jun 18; 1051():779-86. PubMed ID: 16127015 [Abstract] [Full Text] [Related]
18. Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome) Complicated by Perforation of the Small Intestine and Cholecystitis. Ohnuki Y, Moriya Y, Yutani S, Mizuma A, Nakayama T, Ohnuki Y, Uda S, Inomoto C, Yamamoto S, Nakamura N, Takizawa S. Intern Med; 2018 Mar 01; 57(5):737-740. PubMed ID: 29269641 [Abstract] [Full Text] [Related]
20. Low-dose mepolizumab is effective as an add-on therapy for treating long-lasting peripheral neuropathy in patients with eosinophilic granulomatosis with polyangiitis. Nakamura Y, Fukutomi Y, Sekiya K, Kajiwara K, Kawasaki Y, Fujita N, Nagayama K, Iwata M, Iwamoto K, Yano K, Hamada Y, Watai K, Ryu K, Hayashi H, Kamide Y, Taniguchi M. Mod Rheumatol; 2022 Feb 28; 32(2):387-395. PubMed ID: 34910206 [Abstract] [Full Text] [Related] Page: [Next] [New Search]